These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

881 related articles for article (PubMed ID: 21499315)

  • 1. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.
    Ashley CE; Carnes EC; Phillips GK; Padilla D; Durfee PN; Brown PA; Hanna TN; Liu J; Phillips B; Carter MB; Carroll NJ; Jiang X; Dunphy DR; Willman CL; Petsev DN; Evans DG; Parikh AN; Chackerian B; Wharton W; Peabody DS; Brinker CJ
    Nat Mater; 2011 May; 10(5):389-97. PubMed ID: 21499315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.
    Epler K; Padilla D; Phillips G; Crowder P; Castillo R; Wilkinson D; Wilkinson B; Burgard C; Kalinich R; Townson J; Chackerian B; Willman C; Peabody D; Wharton W; Brinker CJ; Ashley C; Carnes E
    Adv Healthc Mater; 2012 May; 1(3):348-53. PubMed ID: 23184753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.
    Butler KS; Durfee PN; Theron C; Ashley CE; Carnes EC; Brinker CJ
    Small; 2016 Apr; 12(16):2173-85. PubMed ID: 26780591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.
    Ashley CE; Carnes EC; Epler KE; Padilla DP; Phillips GK; Castillo RE; Wilkinson DC; Wilkinson BS; Burgard CA; Kalinich RM; Townson JL; Chackerian B; Willman CL; Peabody DS; Wharton W; Brinker CJ
    ACS Nano; 2012 Mar; 6(3):2174-88. PubMed ID: 22309035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles.
    Liu J; Stace-Naughton A; Jiang X; Brinker CJ
    J Am Chem Soc; 2009 Feb; 131(4):1354-5. PubMed ID: 19173660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.
    Ashley CE; Carnes EC; Phillips GK; Durfee PN; Buley MD; Lino CA; Padilla DP; Phillips B; Carter MB; Willman CL; Brinker CJ; Caldeira Jdo C; Chackerian B; Wharton W; Peabody DS
    ACS Nano; 2011 Jul; 5(7):5729-45. PubMed ID: 21615170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor efficacy of irinotecan-loaded galactosyl modified lipid bilayer-coated mesoporous silica nanoparticles against hepatocellular carcinoma cells].
    Chen X; Zhang XX; Li FF; Zhao YN; Jia Z; Gan Y; Li J
    Yao Xue Xue Bao; 2014 May; 49(5):718-25. PubMed ID: 25151746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma.
    Liu M; Tu J; Feng Y; Zhang J; Wu J
    J Nanobiotechnology; 2020 Aug; 18(1):114. PubMed ID: 32811502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells.
    Durfee PN; Lin YS; Dunphy DR; Muñiz AJ; Butler KS; Humphrey KR; Lokke AJ; Agola JO; Chou SS; Chen IM; Wharton W; Townson JL; Willman CL; Brinker CJ
    ACS Nano; 2016 Sep; 10(9):8325-45. PubMed ID: 27419663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma.
    Zhou X; Zhang M; Yung B; Li H; Zhou C; Lee LJ; Lee RJ
    Int J Nanomedicine; 2012; 7():5465-74. PubMed ID: 23093902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective and ATP-driven transport of ions across supported membranes into nanoporous carriers using gramicidin A and ATP synthase.
    Oliynyk V; Mille C; Ng JB; von Ballmoos C; Corkery RW; Bergström L
    Phys Chem Chem Phys; 2013 Feb; 15(8):2733-40. PubMed ID: 23321853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach for targeted delivery to motoneurons using cholera toxin-B modified protocells.
    Gonzalez Porras MA; Durfee PN; Gregory AM; Sieck GC; Brinker CJ; Mantilla CB
    J Neurosci Methods; 2016 Nov; 273():160-174. PubMed ID: 27641118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of in situ PCR-amplified Sleeping Beauty transposon genes to cancer cells with lipid-based nanoparticle-like protocells.
    Ma K; Fu D; Yu D; Cui C; Wang L; Guo Z; Mao C
    Biomaterials; 2017 Mar; 121():55-63. PubMed ID: 28081459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
    Abdelmoneem MA; Elnaggar MA; Hammady RS; Kamel SM; Helmy MW; Abdulkader MA; Zaky A; Fang JY; Elkhodairy KA; Elzoghby AO
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26731-26744. PubMed ID: 31268657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
    Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
    Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy.
    Choi JY; Ramasamy T; Kim SY; Kim J; Ku SK; Youn YS; Kim JR; Jeong JH; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2016 Jul; 39():94-105. PubMed ID: 27163403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden.
    Gao J; Fan K; Jin Y; Zhao L; Wang Q; Tang Y; Xu H; Liu Z; Wang S; Lin J; Lin D
    Eur J Pharm Sci; 2019 Dec; 140():105070. PubMed ID: 31518679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.